Project Grant HT94252410792
Award Date 7/15/24
Completion Date 7/14/28
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded Case Western Reserve University's Office of Research Administration Division, doing business as University Hospitals of Cleveland, a $1,467,210 Project Grant on September 30, 2024. The grant supports research to develop a novel dendritic cell therapy approach for mucosal melanoma, focusing on targeting a differentiation epitope in CD11b of tumor-associated inflammatory monocytes. The research aims...
- The Department of the Army Medical Command awarded Case Western Reserve University a $1,288,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to therapeutically target superclusters at genes driving childhood sarcoma from September 2021 through September 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
- The U.S. Defense Health Agency awarded a $872,237 Project Grant to Case Western Reserve University to conduct "Pulmonary Rehabilitation in Advanced Lung Cancer Survivors" research under the Military Medical Research and Development program (CFDA 12.420). This grant will fund advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The project will run from May 1, 2025 through April 30, 2028 and aims to develop innovative...
- The Department of the Army Medical Command awarded Case Western Reserve University a $795,901 project grant under the Military Medical Research and Development program (CFDA 12.420). The university will develop a novel agent targeting microglial activation induced by therapeutic brain irradiation over a three year period ending August 31, 2025. Through this funding, the awardee aims to investigate medical solutions for the battlefield and transform health care for service members and the...
- This Project Grant award of $471,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by The Cleveland Clinic Foundation to develop next-generation prostate cancer therapeutics by exploiting the allosteric regulation of the androgen receptor. The award period is from September 1, 2023 to August 31, 2025. As a prime recipient of federal grants, The Cleveland Clinic Foundation has a history of...
- This $779,983 Project Grant from the Department of the Army Medical Command supports the "DUAL-TRACER PET IMAGING TO TRACK LIVER CANCER THERAPY" research being conducted by Case Western Reserve University from August 1, 2022 to July 31, 2025. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine. Case Western will use the...
- The federal Project Grant award of $1,578,836.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance) in developing and exploiting a third-generation prostate cancer dependency map to identify cancer vulnerabilities and treatment targets. The award, which runs from August 1, 2024 to July 31, 2027, will enable the research organization to conduct innovative...
- The Case Western Reserve University will receive $1,168,656 in funding from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to support the project "FADD: A MECHANISTIC BASIS AND THERAPEUTIC OPPORTUNITY FOR OVERCOMING CDK4/6 INHIBITOR RESISTANCE" from April 1, 2023 to March 31, 2026. Through this three-year Project Grant, Case Western Reserve University researchers will investigate mechanisms of resistance to...
- Wayne State University was awarded a $1,386,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant will fund a novel strategy targeting the metabolic vulnerability of castration-resistant prostate cancer (CRPC) from July 1, 2023 to June 30, 2026. Through this award, Wayne State University researchers will investigate medical solutions for prostate cancer by developing and applying an innovative approach focused on CRPC's...
- This $480,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research by The Cleveland Clinic Foundation, a non-profit academic medical center, to study the role of the citron kinase protein in castration-resistant prostate cancer. The 2-year project, beginning on May 1, 2024, seeks to gain mechanistic insights that could lead to new therapeutic opportunities for this challenging form of prostate...